by Gloria Jeong | Jul 6, 2022
Pancreatic cancer is one of the most aggressive cancers and five-year survival rates are just 10%. A very small number of patients live longer, with less than 2% surviving more than 10 years after diagnosis. Researchers have been working to understand how this cancer...
by Gloria Jeong | Jun 16, 2022
The Avner Australian Pancreatic Cancer Matrix Atlas group (APMA) will investigate a potential new way to improve immunotherapy outcomes for patients with pancreatic cancer using a class of drug that can reduce the metabolic rewiring of the cancer cells thanks to a...
by Gloria Jeong | Nov 17, 2021
November is recognised as World Pancreatic Cancer Awareness Month. We take time to raise awareness of the disease, celebrate survivors and acknowledge pancreatic cancer research. Pancreatic cancer has now become the third leading cause of cancer deaths...
by Gloria Jeong | Feb 2, 2021
Tanya Dwarte, Associate Genetic Counsellor and Clinical Research Coordinator at the APGI will give a presentation about Genetics and Pancreatic cancer. This webinar will highlight the current understanding of sporadic and inherited forms of pancreatic cancer and...
by Gloria Jeong | Dec 15, 2020
APGI BioResource Project Summary 2020 2020 has been a difficult year for everyone around the world. Our thoughts are with those who have suffered physically and emotionally this year. Despite the challenges here at the APGI we have maintained our commitment to...
